Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-15

Clinical Trial Update: Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

View source ↗

Summary

A completed clinical trial examining whether heavy metal exposure can predict chemotherapy-induced peripheral neuropathy in patients with stage I-III breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Male Breast Cancer, Neurotoxicity | Status: COMPLETED